KMT2A and acute myeloid leukemia: Using MLL-AF9 transduced murine bone marrow cells, previous studies have demonstrated that the AML-selective SE located 1.7 Mbp downstream from the MYC locus is required for AML maintenance in mice and is thought to drive MYC overexpression through long distance enhancer promoter looping interactions with the MYC promoter5,19.